Kraken has introduced new cash-settled options contracts for Bitcoin and Ethereum that settle entirely in US dollars, eliminating the need for traders to hold any cryptocurrency as collateral. These European-style options will initially be available to professional and institutional clients outside Europe, North America, and Australia via a request-for-quote system on Kraken Pro. The move aims to attract institutional investors who prefer dollar-denominated products without dealing with crypto volatility or blockchain interaction. Kraken plans to expand access to European clients later in 2026 and eventually offer a public order book for broader participation.
Hutchison China MediTech Limited (HCM) received a Buy rating upgrade from Daiwa with a new price target of $18.50 following a major licensing deal with GSK. The agreement grants GSK exclusive rights to commercialize HCM's experimental cancer therapy ...
Duluth Holdings reported a strong Q2 earnings per share (EPS) of $0.50, far exceeding the consensus estimate of -$0.01, largely due to $0.44 per share from tariff refunds. Revenue reached $121.39 million, beating estimates but declining from the prev...
Estée Lauder Companies recently appointed new brand leaders, signaling strategic shifts in its competitive beauty market. An insider executive sold 7,766 shares worth over $802,000, leaving no remaining holdings. The company shows a high P/E ratio of...
HUTCHMED's shares surged 17.77% after announcing a major licensing deal with GSK for its preclinical cancer drug HMPL-A830. GSK gets exclusive rights outside Greater China, paying $110 million upfront plus up to $1.295 billion in milestone payments. ...
Genesco reported second-quarter earnings that surpassed analyst expectations, with an EPS loss of $0.83 versus the estimated loss of $1.37 per share. Although revenue fell 3% year-over-year to $529.86 million, the company improved its adjusted gross ...
